Resum
The blood-brain barrier (BBB) is a formidable physical and enzymatic barrier that tightly controls the passage of molecules from the blood to the brain. In fact, less than 2 % of all potential neurotherapeutics are able to cross it. Here, by applying the retro-enantio approach to a peptide that targets the transferrin receptor, a full protease-resistant peptide with the capacity to act as a BBB shuttle was obtained and thus enabled the transport of a variety of cargos into the central nervous system.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 3967-3972 |
Nombre de pàgines | 6 |
Revista | Angewandte Chemie - International Edition |
Volum | 54 |
Número | 13 |
DOIs | |
Estat de la publicació | Publicada - 23 de març 2015 |
Publicat externament | Sí |